Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer

Παρόμοια τεκμήρια

• Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
  ανά: Lazzari, Chiara, κ.ά.
  Έκδοση: (2019)
• Mechanisms of resistance to osimertinib
  ανά: Lazzari, Chiara, κ.ά.
  Έκδοση: (2020)
• Co-mutations in EGFR driven non-small cell lung cancer
  ανά: Rosell, Rafael, κ.ά.
  Έκδοση: (2019)
• Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer
  ανά: Lazzari, Chiara, κ.ά.
  Έκδοση: (2018)
• Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
  ανά: Bracht, Jillian Wilhelmina Paulina, κ.ά.
  Έκδοση: (2019)